From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.

Futureproof, an AI-powered financial intelligence platform helping founders run their startups with clarity and control, today announced it has secured strategic investment from Founder Capital, the ...

Twenty-five years ago, the release of the first complete Arabidopsis thaliana genome marked a pivotal turning point in plant ...

Nanoscope Therapeutics Inc., a biotechnology company committed to developing and commercializing novel, disease-agnostic therapies for patients with photoreceptor loss and vision impairment due to ...

‘Chief Medical Officer’s Annual Report 2025: Infections’ was published at 15:00 UK time on Thursday the 4th of December 2025. Prof Andrew Morris: Andrew is the President of the Academy of Medical ...

Cornell (NY, USA) researchers have found that a new DNA sequencing technology can be used to study how transposons move ...

A TOR-targeting cancer drug unexpectedly extends yeast lifespan through a newly discovered metabolic feedback loop.